Home Cart Sign in  
Chemical Structure| 18228-17-6 Chemical Structure| 18228-17-6
Chemical Structure| 18228-17-6

KG-501

CAS No.: 18228-17-6

KG-501 is histochemical substrate of alkaline phosphatases and can inhibit CREB-CBP interaction.

Synonyms: Naphtholas-ephosphate; 2-naphthol-AS-E-phosphate; Naphthol AS-E phosphate

4.5 *For Research Use Only !

Cat. No.: A631283 Purity: 99%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇò¶ÊÊ Inquiry Inquiry
5mg ł§Ç¶ÊÊ Inquiry Inquiry
10mg łÍʶÊÊ Inquiry Inquiry
50mg łòÿ¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÇò¶ÊÊ

  • 5mg

    ł§Ç¶ÊÊ

  • 10mg

    łÍʶÊÊ

  • 50mg

    łòÿ¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of KG-501

CAS No. :18228-17-6
Formula : C17H13ClNO5P
M.W : 377.72
SMILES Code : O=C(C1=C(OP(O)(O)=O)C=C2C=CC=CC2=C1)NC3=CC=C(Cl)C=C3
Synonyms :
Naphtholas-ephosphate; 2-naphthol-AS-E-phosphate; Naphthol AS-E phosphate
MDL No. :MFCD00042718
InChI Key :RQAQWBFHPMSXKR-UHFFFAOYSA-N
Pubchem ID :87517

Safety of KG-501

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of KG-501

epigenetics

Isoform Comparison

Biological Activity

Target
  • bromodomain

In Vitro:

Cell Line
Concentration Treated Time Description Reference
Human mesenchymal stem cells (hMSCs) 30 µM 1 hour KG-501 abrogated PTH1-34 upregulation of CYP27B1 at both 2 hours and 8 hours PMC3215854
RAW264.7 cells 10 μM 24 hours KG-501 significantly decreased the boosting effect of curcumin on HGF expression PMC8027789
CCD-18Co cells 10 μM 24 hours KG-501 significantly decreased the boosting effect of curcumin on HGF expression PMC8027789
PC12 cells 10 μM 30 min Inhibited HJG-induced neurite outgrowth PMC5702328
Primary microglial cells 25 μM 30 minutes KG-501 completely inhibited BAA-induced CREB phosphorylation and prodynorphin expression. PMC5361206
HEK293T cells 10-25 μM 4 hours KG-501 inhibits CREB-dependent transcription PMC539725
Huh7 cells 10 μM 48 hours Inhibited CREB1 phosphorylation and partially reversed TUFT1 overexpression-induced CREB1 nuclear translocation and lipid accumulation PMC9234046
LNCaP cells 25 μM 48 hours KG-501 inhibited CREB-mediated transcriptional activation and significantly reduced Nurr1 promoter activity PMC4815267
1273/99 0.63-5 μM 72 hours Inhibition of CREB activity reduces downstream target expression, accompanied by suppression of SySa cell proliferation and induction of apoptosis in vitro and in vivo. PMC9187574
FUJI 0.63-5 μM 72 hours Inhibition of CREB activity reduces downstream target expression, accompanied by suppression of SySa cell proliferation and induction of apoptosis in vitro and in vivo. PMC9187574
SYO-I 0.63-5 μM 72 hours Inhibition of CREB activity reduces downstream target expression, accompanied by suppression of SySa cell proliferation and induction of apoptosis in vitro and in vivo. PMC9187574
CME-1 0.63-5 μM 72 hours Inhibition of CREB activity reduces downstream target expression, accompanied by suppression of SySa cell proliferation and induction of apoptosis in vitro and in vivo. PMC9187574
HS-SY-II 0.63-5 μM 72 hours Inhibition of CREB activity reduces downstream target expression, accompanied by suppression of SySa cell proliferation and induction of apoptosis in vitro and in vivo. PMC9187574

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Rats Neuropathic pain model Intrathecal injection 10 μg Single injection KG-501 completely inhibited BAA-induced mechanical antiallodynia. PMC5361206

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.26mL

13.24mL

2.65mL

1.32mL

26.47mL

5.29mL

2.65mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories